ADVERTISEMENT

Top tags

More about this topic

Pharmaceutical companies

Now playing Next

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

Top tags

More about this topic

Now playing Next

Bayer stock soars as German pharma company wins Roundup legal battle

Shares in German pharmaceutical and biotechnology company Bayer climbed nearly 13% on Friday after the company won a legal battle in the US related to its Roundup weedkiller.

16/08/2024

Now playing Next

AstraZeneca leads in valuation as it bets on cancer drugs portfolio

The company has tied up with Eccogene, a Chinese biotech firm, for a new experimental weight loss drug. The weight loss market is currently dominated by Eli Lilly and Novo Nordisk.

14/08/2024

Now playing Next

French-born boss of AstraZeneca named highest-paid CEO in Britain

Pascal Soriot headed a list of top earners compiled by the High Pay Centre, with bosses of Rolls Royce and HSBC also included in the top 10.

12/08/2024

Now playing Next

Novo Nordisk: Earnings trimmed as rivals seek to enter market

Novo Nordisk missed earnings expectations in the second quarter due to growing competition and increased costs from capacity expansions. The company also downgraded its profit outlook for 2024.

07/08/2024

ADVERTISEMENT

Now playing Next

Bayer reaps benefits of demand for new cancer and kidney medicines

German pharmaceutical giant Bayer AG released its second quarter and half year 2024 earnings on Tuesday morning, with the company seeing an average performance in the second quarter, due to the agricultural market environment becoming tougher.

06/08/2024

Now playing Next

Roche plans speedy weight-loss drug launch to catch up with rivals

Roche believes its anti-obesity drugs could have advantages over other more established rivals such as Eli Lilly and Novo Nordisk through ease of scalability that will allow it to meet increased demand.

30/07/2024

Now playing Next

French pharma giant Sanofi ups profit forecast as Dupixent sales soar

The French pharmaceutical firm announces double-digit sales growth in the second quarter thanks to Dupixent and new products.

25/07/2024

Now playing Next

AstraZeneca tops second-quarter earnings forecasts and raises guidance

AstraZeneca exceeded market expectations in its second-quarter earnings report. The British pharmaceutical firm has also upgraded its guidance for fiscal year 2024.

25/07/2024

Now playing Next

Sanofi eyes €1.3 billion investment in insulin drug plant in Germany

Other healthcare companies such as Daiichi Sankyo have also announced investments in Germany recently, in a positive sign for the ruling coalition government.

02/07/2024

Now playing Next

Commission greenlights €1bn cross-border state aid to enhance drug discovery

The EU executive approves investment to fill unmet medical needs with a cross-border state aid scheme to develop and test novel drugs as well as advanced therapy products.

28/05/2024

Now playing Next

This French start-up wants to use AI to get drugs to market faster

French start-up Yseop has partnered with Amazon Web Services (AWS) to use generative AI to assist pharma companies with clinical trials and drug approval.

24/05/2024

Now playing Next

As drug shortages worsen, French NGOs call for more transparency

Pharmaceutical companies’ lack of transparency leads to rising drug prices and less control over public resources, the group of health organisations say.

16/05/2024

Now playing Next

Headache for Bayer as results show fall in Q1 sales and earnings

Mixed earnings results from the German Bayer Group put the pharmaceutical giant's share prices on a rollercoaster ride in Tuesday's early trading.

14/05/2024

Now playing Next

Could a new locally produced drug help Kenya overcome deadly malaria?

The WHO approved a Kenya-based pharma company to produce a crucial antimalarial drug locally, reducing reliance on imports from India and China.

12/05/2024

Now playing Next

Commission’s hospital exemption divides health sector

The inclusion of the hospital exemption for advanced therapies in the new pharmaceutical regulation does not satisfy health organizations and industry amidst accessibility concerns.

03/05/2024

Now playing Next

What is the ‘hospital exemption’, and why does it matter?

A proposed overhaul of EU pharmaceutical rules would impact on the principle of hospital exemption for advance therapies and increase the requirements to ensure uniform implementation.

03/05/2024

Now playing Next

AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand

AstraZeneca continued to see strong earnings boosted primarily by its oncology branch, as well as its respiratory and immunology segment.

25/04/2024

Now playing Next

New Critical Medicines Alliance starts work to address shortages

The European Commission and Belgian Presidency launched a Critical Medicines Alliance to identify weaknesses in supply of drugs in the EU, to better prevent and react to shortages.

25/04/2024

Now playing Next

Commission approves superbug-busting antibiotic

The European Commission today (22 April) authorised a new antibiotic designed to counter anti-bacterial resistance, one of the biggest health threats the EU is currently facing.

22/04/2024

Now playing Next

Letta report highlights need for stronger healthcare sector

Strengthening health resilience is one of the pillars of Enrico Letta’s report on the Single Market to be presented to EU leaders during the special European Council in Brussels today (18 April).

18/04/2024